Menarini Industrie Farmaceutiche Riunite Srl – Pharmaceuticals & Healthcare – market status and trends.  

 

HTF Market Intelligence released a new research report of 51 pages on title ‘A. Menarini Industrie Farmaceutiche Riunite Srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile’  with detailed analysis, forecast and strategies.

Summary

Menarini Industrie Farmaceutiche Riunite Srl (Menarini), formerly Farmacia Internazionale, is a biopharmaceutical company. It undertakes the research, development and manufacture of several pharmaceutical products in various dosage forms. The company’s products portfolio of the company is focused on a range of therapeutic areas including cardiovascular, gastroenterology, antibiotics, respiratory system, diabetes, inflammation and others. It offers its products under three divisions namely, therapeutic and wellness areas, biotechnology and diagnostics. Menarini operates through its manufacturing sites, research and development centers and has presence across Europe and Asia, Africa, Central and South America. It distributes products in more than 100 countries across the world through partners and distributors. Menarini is headquartered in Florence, Italy.

 

  1. Menarini Industrie Farmaceutiche Riunite Srl – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

 

Request a sample report @ https://www.htfmarketreport.com/sample-report/238355-a-menarini-industrie-farmaceutiche-riunite-srl-pharmaceuticals-1 

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

 

Scope

 

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

– Business Description – A brief description of the company’s operations.

– Key Employees – A list of the key executives of the company.

– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.

– Key Competitors – A list of the key competitors of the company.

– Key Recent Developments – A brief on recent news about the company.

 

Reasons to Buy

 

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements

– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

 

Understand the company’s business segments’ expansion / divestiture strategy

– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

 

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company

– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

 

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

 

Stay up-to-date on the major developments affecting the company

– Recent developments concerning the company presented in the profile help you track important events.

 

Gain key insights into the company for academic or business research

– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

 

Note*: Some sections may be missing if data is unavailable for the company.

Make an enquiry before buying this Report @ https://www.htfmarketreport.com/enquiry-before-buy/238355-a-menarini-industrie-farmaceutiche-riunite-srl-pharmaceuticals-1

 

Table of Contents 

Table of Contents  2

List of Tables  4

List of Figures  5

  1. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
  2. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
  3. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
  4. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
  5. Menarini Industrie Farmaceutiche Riunite Srl, Medical Devices Deals, 2011 to YTD 2017 11
  6. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
  7. Menarini Industrie Farmaceutiche Riunite Srl, Pharmaceuticals & Healthcare, Deal Details 15

Asset Purchase  15

Menarini Raunaq Pharma Plans To Acquire Pharma Brands In India For US$80 Million  15

Invida Acquires Dermatology And Primary Care Product Portfolios From Shalaks Pharma For US$20 Million  15

Partnerships  17

Orion Enters into Co-Marketing Agreement with A. Menarini Industrie Farmaceutiche Riunite  17

Menarini Asia-Pacific Enters into Agreement with Merck  17

Menarini Forms Joint Venture with BiosYnth  18

Moberg Pharma Extends Distribution Agreement with Berlin-Chemie for Emtrix  19

Moberg Extends Distribution Agreement with Menarini for Emtrix  20

Moberg Pharma Extends Distribution Agreement With Menarini  21

Moberg Extends Distribution Agreement With Menarini For Kerasal Nail  22

Menarini Enters Into

 

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/238355-a-menarini-industrie-farmaceutiche-riunite-srl-pharmaceuticals-1

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=238355

 

Contact Us:

CRAIG FRANCIS (PR & Marketing Manager)

sales@htfmarketreport.com

Ph: +1 (206) 317 1218

Designed by CyFocus.com
Powered by CyFocus.net